YR, P.; M, B. .; CK , S. . GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF 25 MG FULL TABLET VERSUS 12.5 MG HALF TABLET EMPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES (T2D): A SINGLE CENTRE EXPERIENCE. Journal of the ASEAN Federation of Endocrine Societies, [S. l.], v. 36, p. 44, 2021. DOI: 10.15605/jafes.036.S60. Disponível em: https://asean-endocrinejournal.org/index.php/JAFES/article/view/1483. Acesso em: 5 may. 2024.